Bangalore-based Biocon India has managed to garner a 10 per cent market share of the cholesterol lowering drug lovastatin in the United States in less than six months of its launch.
The company is making rapid inroads into the United States
Biocon Hits Big Time In Us With Lovastatin
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Jan 16 2003 | 12:00 AM IST
